Skip to main content

Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product

    In this report we evaluated patterns of initiation of tacrolimus, an immunosuppressant used to prevent allograft rejection subsequent to organ transplant. In particular, we assessed the number of patients in the Sentinel Distributed Database (SDD) receiving inpatient kidney or liver transplants, duration of SDD follow-up time for these transplant recipients, how many of these patients initiated tacrolimus during their inpatient transplant stay, on the discharge date, and after hospital discharge, and among these initiators, duration of tacrolimus use and reason for censoring.

    Report 1: The study period includes data from August 10, 2009 to February 29, 2020. We distributed this request to 14 Sentinel Data Partners on January 12, 2021.

    Report 2: The study period includes data from August 10, 2009 to December 31, 2019. This request was distributed to the Duke Center for Medicare & Medicaid Services, a contributing Sentinel Distributed Database Data Partner, on January 12, 2021.

    Additional Details
    FDA Center
    Time Period
    August 10, 2009 - February 29, 2020; August 10, 2009 - December 31, 2019
    Analysis Type
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)